Viewing Study NCT05543928


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-06-03 @ 8:18 AM
Study NCT ID: NCT05543928
Status: TERMINATED
Last Update Posted: 2025-07-25
First Post: 2022-09-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Sponsor: OPKO Health, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease stage3 View
None Chronic Kidney Disease stage4 View
None Vitamin d Deficiency View
None Secondary Hyperparathyroidism View
Keywords: